Regeneron Pharmaceuticals (REGN) Assets (2009 - 2026)
Regeneron Pharmaceuticals (REGN) reported Assets of $41.73 billion for Q2 2026, up 9.2% from $38.22 billion a year earlier and up 2.1% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals posted Assets of $40.56 billion, up 7.4% from FY2024.
- Assets has increased for 16 consecutive years, with a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
- By year, Assets came in at $37.76 billion in FY2024 (+14.1%), $33.08 billion in FY2023 (+13.2%), $29.21 billion in FY2022 (+14.9%) and $25.43 billion in FY2021 (+48.2%).
- The Q2 2026 figure ranks as the highest quarterly Assets in data going back to Q4 2009.
- Year over year, Assets has now increased in each of the last 61 quarters, with growth averaging 9.8% over the last eight quarters.
- The year-over-year growth in Assets has ranged between 5.9% (Q2 2025) and 48.3% (Q1 2022) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $40.87 billion (Q1 2026), $40.56 billion (Q4 2025) and $40.17 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 41.73 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.73 Bn |
| Mar 31, 2026 | 40.87 Bn |
| Dec 31, 2025 | 40.56 Bn |
| Sep 30, 2025 | 40.17 Bn |
| Jun 30, 2025 | 38.22 Bn |
| Mar 31, 2025 | 37.55 Bn |
| Dec 31, 2024 | 37.76 Bn |
| Sep 30, 2024 | 37.44 Bn |
| Jun 30, 2024 | 36.09 Bn |
| Mar 31, 2024 | 34.37 Bn |
| Dec 31, 2023 | 33.08 Bn |
| Sep 30, 2023 | 32.16 Bn |
| Jun 30, 2023 | 30.66 Bn |
| Mar 31, 2023 | 30.06 Bn |
| Dec 31, 2022 | 29.21 Bn |
| Sep 30, 2022 | 27.68 Bn |
| Jun 30, 2022 | 27.21 Bn |
| Mar 31, 2022 | 26.35 Bn |
| Dec 31, 2021 | 25.43 Bn |
| Sep 30, 2021 | 23.67 Bn |
API Access
Regeneron Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();